Comparing long-term toxicity and efficacy of combined modality treatment including extended- or involved-field radiotherapy in early-stage Hodgkin's lymphoma.

Radiotherapy-induced malignancies: review of clinical features, pathobiology, and evolving approaches for mitigating risk. Front Oncol (2013) 0.86

Balancing risks and benefits of therapy for patients with favorable-risk limited-stage Hodgkin lymphoma: the role of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy alone. Hematol Oncol Clin North Am (2014) 0.84

Hodgkin lymphoma, version 2.2015. J Natl Compr Canc Netw (2015) 0.82

Radiation-Induced Malignancies Making Radiotherapy a "Two-Edged Sword": A Review of Literature. World J Oncol (2017) 0.75

Radiation-Induced Malignancies: Our Experiences With Five Cases. World J Oncol (2016) 0.75

The genome sequence of Schizosaccharomyces pombe. Nature (2002) 14.26

Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. Proc Natl Acad Sci U S A (1968) 8.67

Herpes-type virus and chromosome marker in normal leukocytes after growth with irradiated Burkitt cells. Science (1967) 8.62

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med (1998) 8.24

Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell (1998) 6.73

Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma. J Virol (1982) 5.49

Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03

Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. Int J Cancer (1988) 4.03

Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, other head and neck neoplasms, and control groups. J Natl Cancer Inst (1970) 3.94

Occurrence of Epstein-Barr virus genomes in human lymphoblastoid cell lines. Nat New Biol (1972) 3.84

Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease. International Database on Hodgkin's Disease Overview Study Group. J Clin Oncol (1998) 3.64

Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood (2000) 3.60

Potential energy barriers to ion transport within lipid bilayers. Studies with tetraphenylborate. Biophys J (1975) 3.56

Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature (1982) 3.26

Demonstration of a herpes group virus in cultures of peripheral leukocytes from patients with infectious mononucleosis. J Virol (1968) 3.09

Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups. J Natl Cancer Inst (1969) 3.07

GroE facilitates refolding of citrate synthase by suppressing aggregation. Biochemistry (1991) 2.92

A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer. Ann Oncol (2005) 2.88

Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis. Aliment Pharmacol Ther (2014) 2.88

Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study. Blood (1998) 2.83

Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD20 monoclonal antibody (rituximab, IDEC-C2B8). Blood (1999) 2.56

Identification of Hodgkin and Sternberg-reed cells as a unique cell type derived from a newly-detected small-cell population. Int J Cancer (1982) 2.51

Rituximab therapy of patients with B-cell chronic lymphocytic leukemia. Blood (2001) 2.50

Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT). Leukemia (2005) 2.24

Four years of experience with silver-copper ionization for control of legionella in a german university hospital hot water plumbing system. Clin Infect Dis (1999) 2.24

European Code Against Cancer and scientific justification: third version (2003). Ann Oncol (2003) 2.17

Sequence and analysis of chromosome 3 of the plant Arabidopsis thaliana. Nature (2000) 2.17

Erythropoietin for patients with malignant disease. Cochrane Database Syst Rev (2004) 2.17

Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood (1996) 2.08

Comparative study of cultured Burkitt tumor cells by immunofluorescence, autoradiography, and electron microscopy. J Virol (1967) 2.07

Gamma/delta T-cell stimulation by pamidronate. N Engl J Med (1999) 2.04

[Diagnosis and therapy of primary stomach lymphoma. Consensus of the Surgical Working Group for Oncology, the Working Group for Medical Oncology and the Working Group for Radiologic Oncology]. Dtsch Med Wochenschr (1997) 1.93

X-ray and optical wave mixing. Nature (2012) 1.92

Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation. Lancet (1997) 1.76

Tracheal intubation and cervical spine excursion: direct laryngoscopy vs. intubating laryngeal mask. Anaesthesia (2001) 1.76

Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials. Ann Oncol (2006) 1.74

Endoscopic diagnosis of acute intestinal GVHD following allogeneic hematopoietic SCT: a retrospective analysis in 175 patients. Bone Marrow Transplant (2011) 1.73

Relation between Epstein-- Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. II. Comparison of cells and sera from patients with Burkitt's lymphoma and infectious mononucleosis. J Exp Med (1968) 1.71

Male gonadal dysfunction in patients with Hodgkin's disease prior to treatment. Ann Oncol (2001) 1.70

Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: a population-matched analysis. Leukemia (2005) 1.70

RNA2 of grapevine fanleaf virus: sequence analysis and coat protein cistron location. J Gen Virol (1990) 1.69

Consolidation with alemtuzumab in patients with chronic lymphocytic leukemia (CLL) in first remission--experience on safety and efficacy within a randomized multicenter phase III trial of the German CLL Study Group (GCLLSG). Leukemia (2004) 1.68

An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab. Ann Oncol (2003) 1.66

[Polyneuropathy following methaqualone (preliminary note)]. Nervenarzt (1973) 1.64

Synergistic sedation with low-dose midazolam and propofol for colonoscopies. Endoscopy (2000) 1.64

Solid tumors in patients treated for Hodgkin's disease: a report from the German Hodgkin Lymphoma Study Group. Ann Oncol (2004) 1.62

Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high-dose conventional conditioning versus fludarabine-based reduced-intensity regimens. Ann Oncol (2002) 1.60

A subcutaneous delta-positive T-cell lymphoma that produces interferon gamma. N Engl J Med (1991) 1.59

Multiple glassy states in a simple model system. Science (2002) 1.58

KRAS mutation in metastatic pancreatic ductal adenocarcinoma: results of a multicenter phase II study evaluating efficacy of cetuximab plus gemcitabine/oxaliplatin (GEMOXCET) in first-line therapy. Oncology (2011) 1.57

Nucleotide sequence of the Bacillus subtilis xylose isomerase gene: extensive homology between the Bacillus and Escherichia coli enzyme. Nucleic Acids Res (1985) 1.57

Immunophenotyping of low-grade B-cell lymphoma in blood and bone marrow: poor correlation between immunophenotype and cytological/histological classification. Br J Haematol (1993) 1.55

A dominant linear B-cell epitope of ricin A-chain is the target of a neutralizing antibody response in Hodgkin's lymphoma patients treated with an anti-CD25 immunotoxin. Clin Exp Immunol (2004) 1.54

[Regression of oesophageal carcinomas after neoadjuvant radiochemotherapy: criteria of the histopathological evaluation]. Pathologe (2004) 1.53

Current status of granulocyte (neutrophil) transfusion therapy for infectious diseases. J Infect Dis (2000) 1.53

Characteristics of Hodgkin's disease-derived cell lines. Cancer Treat Rep (1982) 1.51

Hodgkin's disease: establishment and characterization of four in vitro cell lies. J Cancer Res Clin Oncol (1981) 1.50

Bone marrow involvement in Hodgkin's disease: an analysis of 135 consecutive cases. German Hodgkin's Lymphoma Study Group. J Clin Oncol (1995) 1.50

Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2011) 1.48

Evidence for the detection of the normal counterpart of Hodgkin and Sternberg-Reed cells. Hematol Oncol (1984) 1.47

Remission of refractory Crohn's disease by high-dose cyclophosphamide and autologous peripheral blood stem cell transplantation. Aliment Pharmacol Ther (2012) 1.47

[Results of palmar T-plate osteosynthesis in unstable fractures of the distal radius]. Chirurg (2003) 1.47

Phylogeography and molecular epidemiology of Papaya ringspot virus. Virus Res (2011) 1.46

Clinical-scale single-step CD4(+) and CD8(+) cell depletion for donor innate lymphocyte infusion (DILI). Bone Marrow Transplant (2007) 1.46

Isolation and developmental expression analysis of Enx-1, a novel mouse Polycomb group gene. Mech Dev (1996) 1.45

A new Puumala hantavirus subtype in rodents associated with an outbreak of Nephropathia epidemica in South-East Germany in 2004. Epidemiol Infect (2006) 1.43

C-group chromosome marker in long-term leukocyte cultures. J Natl Cancer Inst (1968) 1.43

Radiotherapy for treatment of localized gastrointestinal non-Hodgkin's lymphoma. Radiother Oncol (1997) 1.43

Hodgkin's disease--environmental or genetic? N Engl J Med (1995) 1.43

Bioelectrical impedance analysis in HIV-infected patients treated with triple antiretroviral treatment. Am J Clin Nutr (1999) 1.42

STAT3 is constitutively activated in Hodgkin cell lines. Blood (2001) 1.42

Tumor cell agglutination and not solely cytokine release as mechanism of adverse reactions during anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) treatment. Blood (2001) 1.41

[Organ preservation in advanced laryngeal and hypopharyngeal carcinoma by primary radiochemotherapy. Results of a multicenter phase II study]. HNO (2002) 1.41

Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin's lymphoma. J Exp Med (2000) 1.40

Variable very-high-energy gamma-ray emission from the microquasar LS I +61 303. Science (2006) 1.40

Combining gemcitabine, oxaliplatin and capecitabine (GEMOXEL) for patients with advanced pancreatic carcinoma (APC): a phase I/II trial. Ann Oncol (2010) 1.40

Correlation of chromosomal aberrations in a myeloma cell line with tumorigenicity in nude mice. Blut (1981) 1.40

Somatic mutation of the CD95 gene in human B cells as a side-effect of the germinal center reaction. J Exp Med (2000) 1.40

Feedback regulation of bile acid synthesis measured by stable isotope kinetics in humans. Eur J Gastroenterol Hepatol (1996) 1.39

Gemcitabine in the treatment of refractory Hodgkin's disease: results of a multicenter phase II study. J Clin Oncol (2000) 1.39

High platelet contamination in progenitor cell concentrates results in significantly lower CD34+ yield after immunoselection. Transfusion (2000) 1.39

An aerobic exercise program for patients with haematological malignancies after bone marrow transplantation. Bone Marrow Transplant (1996) 1.38

Resting energy expenditure, weight loss, and altered body composition in HIV infection. Nutrition (1996) 1.38

Comment on "Intra-abdominal hypertension and abdominal compartment syndrome after endovascular repair of ruptured abdominal aortic aneurysm". Eur J Vasc Endovasc Surg (2011) 1.38

[Quality assurance in surgical and oncological dermatology. Position of VOD (Organization of Oncologic Dermatologists) on therapy of acquired nevus cell nevus. Organization of Oncologic Dermatologists]. Hautarzt (1997) 1.38

Identification of critical nucleotide positions for plastid RNA editing site recognition. RNA (1997) 1.38

Fermi observations of high-energy gamma-ray emission from GRB 080916C. Science (2009) 1.37

Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant (2005) 1.37

Single agent rituximab in patients with follicular or mantle cell lymphoma: clinical and biological factors that are predictive of response and event-free survival as well as the effect of rituximab on the immune system: a study of the Swiss Group for Clinical Cancer Research (SAKK). Ann Oncol (2005) 1.36

Molecular single cell analysis demonstrates the derivation of a peripheral blood-derived cell line (L1236) from the Hodgkin/Reed-Sternberg cells of a Hodgkin's lymphoma patient. Blood (1996) 1.36

[Methodological openness as the basis of integrative psychotherapy]. Psychother Psychosom Med Psychol (2000) 1.34

Mast cells migrate from blood to brain. J Neurosci (2000) 1.34

Extramedullary vs medullary relapse after autologous or allogeneic hematopoietic stem cell transplantation (HSCT) in multiple myeloma (MM) and its correlation to clinical outcome. Bone Marrow Transplant (2004) 1.34

Selective cloning of Bacillus subtilis xylose isomerase and xylulokinase in Escherichia coli genes by IS5-mediated expression. EMBO J (1984) 1.32